abstract |
The present invention relates to compounds of formula (I) (I) It relates to co-crystals of (wherein the co-former molecule is succinic acid or citric acid), methods of making the co-crystals, pharmaceutical compositions thereof, and methods of using the co-crystals to treat or prevent thromboembolic diseases. . |